| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/01/2007 | WO2007023729A1 Sustained-release preparation |
| 03/01/2007 | WO2007023495A2 Method for production of single- and multi-layer microcapsules |
| 03/01/2007 | WO2007023325A2 Controlled release pharmaceutical composition containing carvedilol |
| 03/01/2007 | WO2007023005A1 Device, system, and method comprising microencapsulated proton donor for release of nitric oxide from a polymer |
| 03/01/2007 | WO2007022956A2 Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent |
| 03/01/2007 | WO2007022944A1 Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier |
| 03/01/2007 | WO2007022924A2 Pharmaceutical compositions with melting point depressant agents and method of making same |
| 03/01/2007 | WO2007022890A1 Sterol ester powder |
| 03/01/2007 | WO2007022765A1 Food additive for supplying mineral substances |
| 03/01/2007 | WO2007002780A3 Topical preservative compositions |
| 03/01/2007 | WO2007002345A3 Method for improving water solubility of chitosan |
| 03/01/2007 | WO2006135415A3 Micelles and nanoemulsions for preventative and reactive treatment of atherosclerosis |
| 03/01/2007 | WO2006131591A3 An entacapone-containing oral dosage form |
| 03/01/2007 | WO2006127966A3 Compositions and methods for enhancing axon regeneration |
| 03/01/2007 | WO2006127741A3 Indicia-bearing package for delivery systems for managing release of sensates in an edible composition |
| 03/01/2007 | WO2006127053A3 Controlled release oral delivery systems |
| 03/01/2007 | WO2006119598A3 Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor |
| 03/01/2007 | WO2006117700A3 Process for preparing quetiapine and quetiapine fumarate |
| 03/01/2007 | WO2006113310A3 Nanoparticulate and controlled release compositions comprising prostaglandin derivatives |
| 03/01/2007 | WO2006100602A3 Immediate release stable solid oral dosage forms op fosinopril |
| 03/01/2007 | WO2006100489A3 A transdermal topical composition and its uses |
| 03/01/2007 | WO2006099288A3 Controlled release formulations of octreotide |
| 03/01/2007 | WO2006086992A3 Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands |
| 03/01/2007 | WO2006084164A9 Gastric retention and controlled release delivery system |
| 03/01/2007 | WO2006078948B1 Stable pharmaceutical formulations of zonisamide and methods for their manufacture |
| 03/01/2007 | WO2006078811A3 Pharmaceutical formulations and methods of use |
| 03/01/2007 | WO2006077528A3 Electronically controlled capsule |
| 03/01/2007 | WO2006044202A3 Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid |
| 03/01/2007 | WO2006026064A3 Poly(ionic liquid)s as materials for co2 separation |
| 03/01/2007 | WO2006018501A8 Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 03/01/2007 | WO2006002140A3 Compositions comprising amphotericin b |
| 03/01/2007 | WO2005089224A3 iRNA AGENTS TARGETING VEGF |
| 03/01/2007 | WO2005055983A3 Method of preparation of mixed phase co-crystals with active agents |
| 03/01/2007 | US20070049806 Vascular access port with physiological sensor |
| 03/01/2007 | US20070049552 Fluoroquinolone formulations and methods of making and using the same |
| 03/01/2007 | US20070049531 GLP-1 agonist and cardiovascular complations |
| 03/01/2007 | US20070049519 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals |
| 03/01/2007 | US20070049516 Use of Insulin for the Treatment of Cartilaginous Disorders |
| 03/01/2007 | US20070048385 Microcapsules by coacervation containing a pharmaceutical incorporated in the coating polymer |
| 03/01/2007 | US20070048384 Pharmaceutical compositions |
| 03/01/2007 | US20070048383 Self-assembled endovascular structures |
| 03/01/2007 | US20070048382 for use in spinal surgery; spray-dried hydroxyapatite, radical donor (benzoyl peroxide) and polymethyl methacrylate |
| 03/01/2007 | US20070048381 Methods for promoting growth of bone, ligament, and cartilage |
| 03/01/2007 | US20070048380 Use of an oral dosage with quick release and storage stability: core of omeprazole, lansoprazole or pantoprazole and adjuvants; an intermediate layer having a gastric juice-resistant partially alkali neutralized polymer with cation exchange capacity, and an outer gastric juice resistant layer |
| 03/01/2007 | US20070048379 Valproate tablet |
| 03/01/2007 | US20070048378 Nanoparticulate anticonvulsant and immunosuppressive compositions |
| 03/01/2007 | US20070048377 Drug compositions containing controlled release hypromellose matrices |
| 03/01/2007 | US20070048376 Sustained release formulations of nalbuphine |
| 03/01/2007 | US20070048375 Effervescent preparation of a basic medicinally active substance |
| 03/01/2007 | US20070048374 Bazedoxifene acetate formulations |
| 03/01/2007 | US20070048373 Dried milled granulate and methods |
| 03/01/2007 | US20070048372 Method for treating non-inflammatory osteoarthritic pain |
| 03/01/2007 | US20070048371 Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily |
| 03/01/2007 | US20070048370 Pharmaceutical formulation for salts of monobasic acids with clopidogrel |
| 03/01/2007 | US20070048369 Mucosal delivery tablet |
| 03/01/2007 | US20070048368 A thermoplastic capsule having a softening point of < 200 degrees C. and an orifice formed within; inside an emulsion containing the drug, a surfactant and an oil, also an expandable composition remote from the orifice which expands and expells the emulsion through the aperture at a controlled rate |
| 03/01/2007 | US20070048367 Herbal composition for treating morning sickness |
| 03/01/2007 | US20070048366 Gelatin-based coatings having improved durability |
| 03/01/2007 | US20070048365 Edible coded microsubstrate for pharmaceuticals |
| 03/01/2007 | US20070048364 Free flowing granules containing carbomer |
| 03/01/2007 | US20070048363 chemotherapeutical agent comprising cis-diammoniumdichloro-trans-dihydroxoplatinum(IV) or salts and/or derivatives thereof in the form of capsules, tablets, creams, ointments and infusion solutions; antitumor agents |
| 03/01/2007 | US20070048360 Pharmaceutical compositions with melting point depressant agents and method of making same |
| 03/01/2007 | US20070048359 Exfoliating scrubber |
| 03/01/2007 | US20070048358 Antimicrobial substrates |
| 03/01/2007 | US20070048357 Fibrous wiping products |
| 03/01/2007 | US20070048356 Antimicrobial treatment of nonwoven materials for infection control |
| 03/01/2007 | US20070048355 Non-irritating solvent-borne polymeric coatings for application to the skin |
| 03/01/2007 | US20070048338 Compositions and methods for surface treatment in medical and surgical procedures |
| 03/01/2007 | US20070048337 Aldol-crosslinked polymeric hydrogel adhesives |
| 03/01/2007 | US20070048332 Stabilized liquid anti-RSV antibody formulations |
| 03/01/2007 | US20070048295 Method for preparing alginate capsules |
| 03/01/2007 | US20070048293 Manipulation of PTEN in T cells as a strategy to modulate immune responses |
| 03/01/2007 | US20070048291 Method and material for enhanced tissue-biomaterial integration |
| 03/01/2007 | US20070048261 Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases |
| 03/01/2007 | US20070048231 Pheromone compositions and methods |
| 03/01/2007 | US20070048230 Pheromone compositions and methods |
| 03/01/2007 | US20070048229 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; blocking effects of acetylcholine at muscarine receptors |
| 03/01/2007 | US20070045890 Calcium carbonate granulation |
| 03/01/2007 | US20070044795 Method and apparatus for dispensing inhalator medicament |
| 03/01/2007 | US20070044729 Amusement articles possessing microbe-inhibiting properties |
| 03/01/2007 | DE202004021169U1 Pharmazeutische Formulierung, die Lanthanverbindungen enthält A pharmaceutical formulation containing lanthanum compounds |
| 03/01/2007 | DE19960225B4 Kristallines, in der asymmetrischen Einheit mindestens eine an der Katalyse beteiligte (Sub)-Domaine eines humanen m-Calpains aufweisendes Polypeptid, Verfahren zur Identifizierung von Verbindungen unter dessen Verwendung, Verfahren zu dessen Kristallisation und Verfahren zur Darstellung einer 3-dimensionalen Struktur dieses Peptids Crystalline, in the asymmetric unit, at least one involved in catalysis (Sub) -Domaine a human m-calpain polypeptide having, methods for identifying compounds with its use, method of crystallization and method for displaying a 3-dimensional structure of this peptide |
| 03/01/2007 | DE102006030444A1 Sperrschicht für Nahrungsteilchen Barrier for food particles |
| 03/01/2007 | DE102005040429A1 Wirkstofffreisetzungssystem und seine Verwendung The drug delivery system and its use |
| 03/01/2007 | DE102005040251A1 Transcorneales System zur Abgabe eines Arzneimittel-Wirkstoffes Transcorneal system for delivering a drug-drug |
| 03/01/2007 | CA2816276A1 Balsalazide formulations and manufacture and use thereof |
| 03/01/2007 | CA2622904A1 Self-assembling nanoparticles for the treatment of vascular diseases |
| 03/01/2007 | CA2620829A1 Method of storing nanoparticle formulations |
| 03/01/2007 | CA2620259A1 Sustained-release preparation |
| 03/01/2007 | CA2620224A1 Sustained release formulations of nalbuphine |
| 03/01/2007 | CA2620198A1 Food additive for supplying mineral nutrients |
| 03/01/2007 | CA2620174A1 Bazedoxifene acetate formulations and manufacturing process thereof |
| 03/01/2007 | CA2620108A1 Drug compositions containing controlled release hypromellose matrices |
| 03/01/2007 | CA2620026A1 Method for production of single- and multi-layer microcapsules |
| 03/01/2007 | CA2619834A1 Stabilized and preserved ketotifen ophthalmic compositions |
| 03/01/2007 | CA2619715A1 Pharmaceutical compositions with melting point depressant agents and method of making same |
| 03/01/2007 | CA2619601A1 Long acting injectable parasiticidal formulations |
| 03/01/2007 | CA2619582A1 Stabilized and preserved ketotifen ophthalmic compositions |
| 03/01/2007 | CA2619568A1 Topical formulations of histone deacetylase inhibitors and methods of using the same |
| 03/01/2007 | CA2619426A1 Exendin for treating diabetes and reducing body weight |